In the second part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

While the Trump administration’s latest executive order touts sweeping drug price cuts through international benchmarking, ...

A research team from the University of Oklahoma has pioneered a method that could accelerate drug discovery and reduce ...

President Donald Trump signed a new executive order Monday aimed at slashing the cost of prescription drugs in the United ...

CROs Advance Pharmaceutical Innovation with Thermo Fisher Scientific In today’s fast-paced pharmaceutical landscape, Contract ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

GSK has stopped development of anti-TIGIT antibody belrestotug. | GSK has stopped development of anti-TIGIT antibody ...

Factors Affecting the Growth of the Artificial Intelligence For Drug Development and Discovery Industry: ...

On Sunday, Trump took aim at the industry again, writing that the “Pharmaceutical/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs ...

The order asks drug companies to ... policy will ensure that the cost is shared among several nations. "There will still be plenty of money for research and development purposes, but it's just ...